Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Cited by (1,010)

Items 301–400 of 1,010

1. HMGB1 Promotes Drug Resistance in Osteosarcoma
   Jun Xing Huang, Jiangdong Ni, Ke Liu, Yan Hui Yu, Min Xie, Rui Kang, Philip Joseph Vernon, Lizhi Cao, Daolin Tang · 2011 · Cancer Research
2. The Effect of Radiation on the Immune Response to Cancers
   Bonggoo Park, Cassian Yee, Kyung‐Mi Lee · 2014 · International Journal of Molecular Sciences
3. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice
   Santiago Zelenay, Anna M. Keller, Paul G. Whitney, Barbara U. Schraml, Safia Deddouche, Neil C. Rogers, Oliver Schulz, David Sancho, Caetano Reis e Sousa · 2012 · Journal of Clinical Investigation
4. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
   Jun Zhao, Xiaofei Wen, Tian Xiang Li, Tingting Li, Chunyu Xu, Xiaoxia Wen, Marites Pasuelo Melancon, Sanjay Kumar Gupta, Baozhong Shen, Weiyi Peng et al. · 2019 · Nature Communications
5. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
   Garg, Abhishek D., Vandenberk, Lien, Koks, Carolien, Verschuere, Tina, Boon, Louis, Van Gool, Stefaan W., Agostinis, Patrizia · 2016 · Science Translational Medicine
6. Whole Tumor Antigen Vaccines: Where Are We?
   Cheryl Lai-Lai Chiang, George Coukos, Lana Elias Kandalaft · 2015 · Vaccines
7. Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers
   Yelei Guo, Kaichao Feng, Yang Liu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Hejin Jia, Weidong Han · 2017 · Clinical Cancer Research
8. Autophagy: shaping the tumor microenvironment and therapeutic response
   Hannelore Maes, Noemí Rubio, Abhishek Dinkarnath Garg, Patrizia Agostinis · 2013 · Trends in Molecular Medicine
9. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
   Alfonso R. Sánchez-Paulete, Álvaro Teijeira, Francisco J. Cueto, Saray Garasa, José Luis Perez‐Gracia, Álvaro Sánchez-Arráez, David Sancho, Ignacio Melero · 2017 · Annals of Oncology
10. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
    Mikako Ogawa, Yusuke Tomita, Yuko Nakamura, Min-Jung Lee, Sunmin Lee, Saori Tomita, Tadanobu Nagaya, Kazuhide Sato, Toyohiko Yamauchi, Hidenao Iwai et al. · 2017 · Oncotarget
11. Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
    Gi‐Hoon Nam, Yoonjeong Choi, Gi Beom Kim, Seohyun Kim, Seong A Kim, In‐San Kim · 2020 · Advanced Materials
12. Trial watch
    Erika Vacchelli, Laura Senovilla, Alexander M.M. Eggermont, Wolf H. Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2013 · OncoImmunology
13. Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
    Qiang Wang, Xiaoli Ju, Jiayou Wang, Yu Jing Fan, Meijia Ren, Heng Zhang · 2018 · Cancer Letters
14. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
    Takahiro Yamazaki, Dalil Hannani, Vichnou Poirier-Colame, Sylvain Ladoire, Clara Locher, Antonella Sistigu, Nicole Prada, Sandy Adjemian, João Paulo Portela Catani, Marina A. Freudenberg et al. · 2013 · Cell Death and Differentiation
15. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
    Urszula Cytlak, Douglas P. Dyer, Jamie Honeychurch, Kaye Janine Williams, Mark A. Travis, Tim Illidge · 2021 · Nature reviews. Immunology
16. Oxidative stress-mediated HMGB1 biology
    Yu Qing Yan, Daolin Tang, Rui Kang · 2015 · Frontiers in Physiology
17. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
    Qianfei Zhang, Chi Ma, Yi Duan, Bernd Heinrich, Umberto Rosato, Laurence P. Diggs, Lichun Ma, Soumen Roy, Qiong Fu, Zachary J. Brown et al. · 2020 · Cancer Discovery
18. PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism
    Changfeng Li, Ying Zhang, Xing Cheng, Hua Yuan, Shan Zhu, Jiao Liu, Qirong Wen, Yangchun Xie, Jinbao Liu, Guido Kroemer et al. · 2018 · Developmental Cell
19. Cytosolic DNA Sensing in Organismal Tumor Control
    Vanpouille-Box, Claire, Demaria, Sandra, Formenti, Silvia C., Galluzzi, Lorenzo · 2018 · Cancer Cell
20. Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
    Duan, Xiaopin, Chan, Christina, Han, Wenbo, Guo, Nining, Weichselbaum, Ralph R., Lin, Wenbin · 2019 · Nature Communications
21. Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
    Jason R. Baird, David J. Friedman, Benjamin Cottam, Thomas Walter Dubensky, David B. Kanne, Shelly Bambina, Keith S. Bahjat, Marka R. Crittenden, Michael J. Gough · 2015 · Cancer Research
22. New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
    Stanley L. Liauw, Philip P. Connell, Ralph R. Weichselbaum · 2013 · Science Translational Medicine
23. Resolvins suppress tumor growth and enhance cancer therapy
    Megan L. Sulciner, Charles Nicholas Serhan, Molly M. Gilligan, Dayna K. Mudge, Jaimie Chang, Allison Gartung, Kristen A. Lehner, Diane Renee Bielenberg, Birgitta A. R. Schmidt, Jesmond Dalli et al. · 2017 · The Journal of Experimental Medicine
24. Radiation and Inflammation
    Dörthe Schaue, Ewa D. Micewicz, Josephine A. Ratikan, Michael W. Xie, Genhong Cheng, William H. McBride · 2014 · Seminars in Radiation Oncology
25. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
    Xiao Ling Zhao, Keni Yang, Ruifang Zhao, Tianjiao Ji, Xiuchao Wang, Xiao Yang, Yinlong Zhang, Keman Cheng, Shaoli Liu, Jihui Hao et al. · 2016 · Biomaterials
26. Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity
    K. Tsuchiya · 2021 · International Journal of Molecular Sciences
27. First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
    Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, Etienne G.C. Brain, Rosana Jarcau, Frédérique Cvitkovic, Nabil Bousetta, Jacques Médioni, Joseph Gligorov, Caroline Grygar et al. · 2010 · Journal of Translational Medicine
28. Risk of Cancer in Patients With Autoimmune Pancreatitis
    Masahiro Shiokawa, Yuzo Kodama, Kenichi Yoshimura, Chiharu Kawanami, Jun Mimura, Yukitaka Yamashita, Masanori Asada, Masataka Kikuyama, Yoshihiro Okabe, Tetsuro Inokuma et al. · 2013 · The American Journal of Gastroenterology
29. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
    Minoru Miyashita, Hironobu Sasano, Kentaro Tamaki, Hisashi Hirakawa, Yayoi Takahashi, Saki Nakagawa, Gou Watanabe, Hiroshi Tada, Akihiko Suzuki, Noriaki Ohuchi et al. · 2015 · Breast Cancer Research
30. Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
    Mirosław J. Szczepański, Malgorzata Czystowska, Marta E. Szajnik, Malgorzata Harasymczuk, Michael M. Boyiadzis, Aleksandra Kruk - Zagajewska, Witold Szyfter, J Zeromski, Theresa L. Whiteside · 2009 · Cancer Research
31. STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
    Takayuki Ohkuri, Arundhati Ghosh, Akemi Kosaka, Jianzhong Zhu, Maki Ikeura, Michael David, Simon C. Watkins, Saumendra N. Sarkar, Hideho Okada · 2014 · Cancer Immunology Research
32. Old and new facts about hyperthermia-induced modulations of the immune system
    Benjamin Frey, Eva‐Maria Weiss, Yvonne Rubner, Roland Wunderlich, Oliver Josef Ott, Rolf Sauer, Rainer Fietkau, Udo S. Gaipl · 2012 · International Journal of Hyperthermia
33. Inducers of immunogenic cancer cell death
    Aleksandra M. Dudek, Abhishek Dinkarnath Garg, Dmitri V. Krysko, Dirk De Ruysscher, Patrizia Agostinis · 2013 · Cytokine & Growth Factor Reviews
34. Chemoimmunotherapy: Reengineering Tumor Immunity
    Chen, Gang, Emens, Leisha A. · 2013 · Cancer Immunology, Immunotherapy
35. Cancer and Inflammation: Implications for Pharmacology and Therapeutics
    Frances R. Balkwill, Alberto Mantovani · 2010 · Clinical Pharmacology & Therapeutics
36. Biological effects of radiation on cancer cells
    Jinsong Wang, Haijuan Wang, Haili Qian · 2018 · Military Medical Research
37. Whole tumor antigen vaccines
    Cheryl Lai-Lai Chiang, Fabián Benencia, George Coukos · 2010 · Seminars in Immunology
38. Trial watch
    Erika Vacchelli, Ilio Vitale, Alexander M.M. Eggermont, Wolf H. Fridman, Jitka Palich Fucikova, Isabelle Cremer, Jérôme Galon, Éric Tartour, Laurence Zitvogel, Guido Kroemer et al. · 2013 · OncoImmunology
39. Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy
    Tsuguhide Takeshima, Kenji Chamoto, Daiko Wakita, Takayuki Ohkuri, Yuji Togashi, Hiroki Shirato, Hidemitsu Kitamura, Takashi Nishimura · 2010 · Cancer Research
40. Radiation effects on antitumor immune responses: current perspectives and challenges
    Thomas Walle, Rafael Martìnez Monge, Adelheid Cerwenka, Daniel Ajona, Ignacio Melero, Fernando Lecanda · 2018 · Therapeutic Advances in Medical Oncology
41. eIF2α phosphorylation is pathognomonic for immunogenic cell death
    Lucillia Bezu, Allan Sauvat, Juliette F Humeau, Lígia Catarina Gomes-da-Silva, Kristina Iribarren, Sabrina Forveille, Pauline Garcia, Liwei Zhao, Peng Liu, Laurence Zitvogel et al. · 2018 · Cell Death and Differentiation
42. Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
    Galina V. Shurin, Irina L. Tourkova, Ramon Kaneno, Michael R. Shurin · 2009 · The Journal of Immunology
43. Immunogenic cell death
    Abhishek Dinkarnath Garg, Aleksandra M. Dudek-Perić, Erminia Romano, Patrizia Agostinis · 2015 · The International Journal of Developmental Biology
44. Inflammation and immune surveillance in cancer
    Melvyn T. Chow, Andreas Möller, Mark John Smyth · 2011 · Seminars in Cancer Biology
45. HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
    Katherine H. Parker, Pratima Sinha, Lucas A. Horn, Virginia K. Clements, Huan Yang, Jianhua Li, Kevin J. Tracey, Suzanne Ostrand‐Rosenberg · 2014 · Cancer Research
46. Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus–Related Head and Neck Cancer
    William Charles Spanos, Paul Nowicki, Dong Wook Lee, Andrew C. Hoover, Bruce S. Hostager, Anjali Gupta, Mary E. Anderson, John H. Lee · 2009 · Archives of Otolaryngology - Head and Neck Surgery
47. Mechanisms of immune activation and regulation: lessons from melanoma
    Shelly Kalaora, Adi Nagler, Jennifer Ann Wargo, Yardena Samuels · 2022 · Nature reviews. Cancer
48. Combinations of Immunotherapy and Radiation in Cancer Therapy
    Ralph E. Vatner, Benjamin Thomas Cooper, Claire Vanpouille‐Box, Sandra Demaria, Silvia Chiara Formenti · 2014 · Frontiers in Oncology
49. Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses
    Yu Chao, Chao Liang, Huiquan Tao, Yaran Du, Di Wu, Ziliang Dong, Qiutong Jin, Guobin Chen, Jun Xu, Zhisheng Xiao et al. · 2020 · Science Advances
50. Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
    Hazem Ghebeh, Cynthia L. Lehé, Eman Barhoush, Khaldoun I. Al-Romaih, Asma M. Tulbah, Monther M Al-Alwan, Siti‐Faujiah Hendrayani, Pulicat Subramanian Manogaran, Ayodele A. Alaiya, Taher Al‐Tweigeri et al. · 2010 · Breast Cancer Research
51. Alarmins link neutrophils and dendritic cells
    De Yang, Gonzalo de la Rosa, Poonam Tewary, Joost J. Oppenheim · 2009 · Trends in Immunology
52. Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
    Li, Yingzhong, Su, Zhijun, Zhao, Weiyu, Zhang, Xinfu, Momin, Noor, Zhang, Chengxiang, Wittrup, K. Dane, Dong, Yizhou, Irvine, Darrell J., Weiss, Ron · 2020 · Nature Cancer
53. Crosstalk between ER stress and immunogenic cell death
    Oliver Kepp, Laurie Menger, Erika Vacchelli, Clara Locher, Sandy Adjemian, Takahiro Yamazaki, Isabelle Martins, Abdul Qader Sukkurwala, Michael Michaud, Laura Senovilla et al. · 2013 · Cytokine & Growth Factor Reviews
54. Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis
    Abhishek Dinkarnath Garg, Dirk De Ruysscher, Patrizia Agostinis · 2015 · OncoImmunology
55. Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally
    Maria Angela Aznar, Nicola Tinari, Antonio Rullan, Alfonso R. Sánchez-Paulete, Maria Esperanza Rodriguez-Ruiz, Ignacio Melero · 2016 · The Journal of Immunology
56. Radiation-induced effects and the immune system in cancer
    Punit Kaur, Alexzander A. A. Asea · 2012 · Frontiers in Oncology
57. HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products
    Yanghua Qin, Sheng‐Ming Dai, Gusheng Tang, Jun Zhang, Ding Ren, Zhiwei Wang, Qian Shen · 2009 · The Journal of Immunology
58. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression
    Hossain, Dewan Md Sakib, Javaid, Sarah, Cai, Mingmei, Zhang, Chunsheng, Sawant, Anandi, Hinton, Marlene, Sathe, Manjiri, Grein, Jeff, Blumenschein, Wendy, Pinheiro, Elaine M. et al. · 2018 · Journal of Clinical Investigation
59. Relevance of tumor-infiltrating lymphocytes in breast cancer
    Sathana Dushyanthen, Paul A. Beavis, Peter Stephen Savas, Zhi Ling Teo, Chenhao Zhou, Mariam Mansour, Phillip Kevin Darcy, Sherene Loi · 2015 · BMC Medicine
60. OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
    Daniel Hirschhorn-Cymerman, Gabrielle A. Rizzuto, Taha Merghoub, Adam D. Cohen, Francesca Avogadri, Alexander M. Lesokhin, Andrew D. Weinberg, Jedd D. Wolchok, Alan N. Houghton · 2009 · The Journal of Experimental Medicine
61. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
    Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Palich Fucikova, Radek Špíšek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi et al. · 2020 · OncoImmunology
62. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
    Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed I. A. Younes, Mauricio S. Caetano, Hari Menon, Nathan I. Comeaux, Taylor R. Cushman, Jonathan E. Schoenhals, Alexandra P. Cadena, Timothy P. Reilly et al. · 2020 · Journal for ImmunoTherapy of Cancer
63. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
    Emeric Limagne, Lisa Nuttin, Marion Thibaudin, Élise Jacquin, Romain Aucagne, Marjorie Bon, Solène Revy, Robby Barnestein, Elise Ballot, Caroline Truntzer et al. · 2022 · Cancer Cell
64. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Sylvain Ladoire, Grégoire Mignot, Tienhan Sandrine Dabakuyo‐Yonli, Laurent Arnould, Lionel Apétoh, Cédric Rébé, Bruno P. Coudert, François Martin, Marie-Hélène Bizollon, André Vanoli et al. · 2011 · The Journal of Pathology
65. A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
    Chrystelle Brignone, Bernard J. Escudier, Caroline Grygar, Manon Marcu, Frédéric Triebel · 2009 · Clinical Cancer Research
66. Danger signalling during cancer cell death: origins, plasticity and regulation
    Abhishek Dinkarnath Garg, S Martin, Jakub Gołąb, Patrizia Agostinis · 2013 · Cell Death and Differentiation
67. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation
    Lee, Chun Seng · 2014 · World Journal of Gastroenterology
68. Important aspects of Toll-like receptors, ligands and their signaling pathways
    Z. Chang · 2010 · Inflammation Research
69. Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
    Sylvia Adams, Lina Kozhaya, Frank T. Martiniuk, Tze‐Chiang Meng, Luis A. Chiriboga, Leonard Liebes, Tsivia Hochman, Nicholas Shuman, Deborah Axelrod, James L. Speyer et al. · 2012 · Clinical Cancer Research
70. Innate and adaptive immune responses to cell death
    Kenneth L. Rock, Jiann‐Jyh Lai, Hajime Kono · 2011 · Immunological Reviews
71. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells
    Christophe Yannick Calvet, Delphine Famin, Franck M. André, Lluis M. Mir · 2014 · OncoImmunology
72. Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation
    InYoung Kim, Yu‐Ying He · 2014 · Genes & Diseases
73. Regulation of Tumor Progression by Programmed Necrosis
    Su Yeon Lee, Min Kyung Ju, Hyun Min Jeon, Eui Kyong Jeong, Yig Ji Lee, Cho Hee Kim, Hye Gyeong Park, Song Iy Han, Ho Sung Kang · 2018 · Oxidative Medicine and Cellular Longevity
74. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
    Jianqin Lu, Xiangsheng Liu, Yu‐Pei Liao, Xiang Wang, Ayman Ahmed, Wen Jiang, Ying Chao Ji, Huan Meng, André E. Nel · 2018 · ACS Nano · Retracted
75. Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
    Yuchen Fan, Rui Kuai, Yao Xu, Lukasz J. Ochyl, Darrell J. Irvine, James Jaehyun Moon · 2017 · Nano Letters
76. Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
    Michail Ignatiadis, Sandeep Kumar Singhal, Christine Desmedt, Benjamin Haibe‐Kains, Carmen Criscitiello, Fabrice André, Sherene Loi, Martine J Piccart, Stefan Michiels, Christos P. Sotiriou · 2012 · Journal of Clinical Oncology
77. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
    Yoshiyuki Suzuki, Kousaku Mimura, Yuya Yoshimoto, Mitsuaki Watanabe, Yu Ohkubo, Shinichirou Izawa, Kazutoshi Murata, Hideki Fujii, Takashi Nakano, Koji Kono · 2012 · Cancer Research
78. Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies
    Lionel Apétoh, Antoine Tesnière, François Ghiringhelli, Guido Kroemer, Laurence Zitvogel · 2008 · Cancer Research
79. Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy
    Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges, Haihua Xiao · 2023 · Angewandte Chemie International Edition
80. Innate Immunity and Cancer Pathophysiology
    Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun, Mikala Egeblad · 2021 · Annual Review of Pathology Mechanisms of Disease
81. ER-Targeting Cyanine Dye as an NIR Photoinducer to Efficiently Trigger Photoimmunogenic Cancer Cell Death
    He Ma, Lu Gang Yang, Zhibin Huang, Saran Long, Jianfang Cao, Zhen Zhang, Xiao Yan Zhou, Chao Shi, Wen Ce Sun, Jianjun Du et al. · 2022 · Journal of the American Chemical Society
82. Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
    Zhenyu Cai, Amir Sanchez, Zhongcheng Shi, Tingting Zhang, Mingyao Liu, Dekai Zhang · 2011 · Cancer Research
83. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
    Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel, Zoila Areli Lopez Bujanda, Debebe Theodros, Wendy Mao, Maria A. Carrera-Haro, Ali Ghasemzadeh, Ariel E. E. Marciscano, Esteban Velarde et al. · 2017 · Cancer Immunology Research
84. Mechanisms and management of doxorubicin cardiotoxicity
    Y. Shi, Mark S. Moon, S. Dawood, Bruce M. McManus, P.P. Liu · 2011 · Herz
85. Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer
    Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo Felipe Kuperman Benveniste, Jianjun J. Zhang, Emily B. Roarty, Lara Lacerda, Stephen G. Swisher, John Victor Heymach et al. · 2017 · Lung Cancer
86. Metal-Based Photosensitizers as Inducers of Regulated Cell Death Mechanisms
    Yiyi Zhang, Bich‐Thuy Doan, Gilles Gasser · 2023 · Chemical Reviews
87. Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
    Zachary S. Buchwald, Jacob Frank Wynne, Tahseen H. Nasti, Simeng Zhu, Waleed Fouad Mourad, Weisi Yan, Seema Gupta, Samir N. Khleif, Mohammad Khurram Khan · 2018 · Frontiers in Oncology
88. Molecular mechanisms of natural killer cell activation in response to cellular stress
    C J Chan, Mark John Smyth, Ludovic Martinet · 2013 · Cell Death and Differentiation
89. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
    Marion Dajon, Kristina Iribarren, Isabelle Cremer · 2016 · Immunobiology
90. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme
    Padma Kadiyala, Dan Li, Fernando M. Núñez, David B. Altshuler, Robert Doherty, Rui Kuai, Minzhi Yu, Neha Kamran, Marta B. Edwards, James Jaehyun Moon et al. · 2019 · ACS Nano
91. Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
    Weishi Cheng, Kai Kang, Ailin Zhao, Yijun Wu · 2024 · Journal of Hematology & Oncology
92. PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
    Magalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, Romain Boidot, Frédérique Végran, Aurélie Roussey, Fanny Chalmin, Lucile Dondaine, Catherine Paul, Elodie Lauret Marie Joseph et al. · 2018 · OncoImmunology
93. Nanoscale theranostics for physical stimulus-responsive cancer therapies
    Qian Chen, Hengte Ke, Zhifei Dai, Zhuang Liu · 2015 · Biomaterials
94. The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
    Nicole Rufo, Abhishek Dinkarnath Garg, Patrizia Agostinis · 2017 · Trends in cancer
95. Origin and Consequences of Necroinflammation
    Maysa Sarhan, Walter Gottlieb Land, Wulf Tonnus, Christian Hugo, Andreas Linkermann · 2018 · Physiological Reviews
96. Polarized immune responses differentially regulate cancer development
    Magnus Johansson, David G. DeNardo, Lisa M. Coussens · 2008 · Immunological Reviews
97. Biological role of Toll-like receptor-4 in the brain
    Teresa Trotta, Chiara Porro, Rosa Calvello, Maria Antonietta Panaro · 2014 · Journal of Neuroimmunology
98. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
    Hongliang Fang, Bing Ang, Xinyun Xu, Xiaohui Huang, Yanfeng Wu, Yanping Sun, Wenying Wang, Nan Li, Xuetao Cao, Tao Yu Wan · 2013 · Cellular and Molecular Immunology
99. Cancer‐promoting tumor‐associated macrophages: New vistas and open questions
    Alberto Mantovani, Giovanni Germano, Federica Marchesi, Marco Locatelli, Subhra Kumar Biswas · 2011 · European Journal of Immunology
100. Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death
     Carolien Koks, Abhishek Dinkarnath Garg, Michael Ehrhardt, Mattéo Riva, Lien Vandenberk, Louis Boon, Steven De Vleeschouwer, Patrizia Agostinis, Norbert M. Graf, Stefaan Van Gool · 2014 · International Journal of Cancer